Refine by
Applications
- Actionable Molecular Diagnostic System for Physicians
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Diagnostic Tests Kit for Bladder Cancer
- Diagnostic Tests Kit for Prostate Cancer
- ExactVu - Micro-Ultrasound System for Transrectal Targeted Biopsy
- ExactVu - Micro-Ultrasound System for Transperineal Targeted Biopsies
- Isotopes for Medical
- Fusion - Bx - Semi-Robotic Arm System for Physicians
- Fusion - Bx - Semi-Robotic Arm System for Patients
Prostate Tumors Equipment & Supplies
275 equipment items found
Manufactured by:biolitec AG based inWien, AUSTRIA
biolitec offers an extensive product range for urologic laser applications – state-of-the-art laser systems, fibers, handpieces, and other accessories. Thus you will be well equipped for the advanced treatment of BPH, bladder tumors, prostate tumors, partial kidney resection, condylomas, stricture, etc. ...
by:Pars Isotope Co based inTehran, IRAN
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to prostate tumor cells, facilitating the destruction of malignant cells. This unique action stems from its characteristic as a gamma ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Melengestrol Acetate is used as a contraceptive agent for growth promoting effects and suppression of estrus in animals. Melengestrol acetate inhibits both the androgen-dependent and -independent prostatic tumors in vivo and can be used for cancer ...
Manufactured by:Shine Technologies based inJanesville, WISCONSIN (USA)
SHINE Technologies’ isotope production process is enabling treatment options that have the potential to improve outcomes for patients being treated for a range of cancers, such as prostate cancer. SHINE’s current focus includes production of non-carrier-added lutetium-177. The unique advantages of our n.c.a. Lu-177 production process include an exclusive processing technology, ...
Manufactured by:Triopsy Medical, Inc. based inAurora, COLORADO (USA)
Our disruptive and innovative technology is addressing a significant and unmet need - that is, to diagnose cancer more accurately and earlier. We are targeting a well-defined market opportunity with accessible channels of distribution and are pursuing a streamlined 510(k) regulatory pathway with go-to-market strategy planned for 2022. Reimbursement codes already exist for our planned products ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Thymosin β15 is a small actin-binding protein upregulated in highly metastatic rat prostate cancer cells, relative to low metastatic cells.http://www.creative-peptides.com/product/thymosin-item-10-101-100-109.html ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Triptorelin acetate is a potent LHRH agonist. It can result in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. For most prostate cancers, they need the hormone testosterone in order to grow. Almost all testosterone in men is made by the testicles. Triptorelin stops the testicles from making testosterone. This reduces testosterone ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
Pivalate is the invention of Professor Eric Aboagye of Imperial College London: Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilises the early steps of fatty acid oxidation and is very stable; In comparison to the clinical standard in PET imaging, 18F-FDG in prostate and brain cancers, Pivalate showed superior imaging performance and was equally good for two ...
Manufactured by:Vitro Biopharma based inGolden, COLORADO (USA)
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen (1% - 5% O2). Available for research ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
A Prostate-Specific Membrane Antigen (PSMA) imaging agent for the detection & staging of prostate ...
Manufactured by:LAVA Therapeutics N.V. based inUtrecht, NETHERLANDS
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic castration-resistant prostate cancer in the second half of ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
PSA-mAb is the invention of Professor David Ulmert formerly of Memorial Sloan Kettering and now ...
Manufactured by:Focal Healthcare based inToronto, ONTARIO (CANADA)
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm of the Fusion Bx allows you to effortlessly maneuver the probe to accurately locate and target suspicious regions of interest. An unrestricted range of motion allows freehand-like access to the entire ...
Manufactured by:Intramedical Imaging, LLC based inHawthorne, CALIFORNIA (USA)
Available Tip Sizes: 5mm, 10mm; Node Biopsy/Mapping in Cervical, Prostate and Gastric ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
PR Sera Dx Immunoassay test panel for detection of the presence of prostate cancer and discrimination of benign prostate hyperplasia (BPH) and aggressive from non ...
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). ...
Manufactured by:Care Wise Medical Products Corporation based inHENFIELD, UNITED KINGDOM
Designed for Laparoscopic Applications such as Cervical, Prostate and Gastric Cancer. ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing testosterone levels can cause the cancer cells to die, thus reducing the size of the tumour and delaying its growth. To date, FIRMAGON has been approved in 74 countries. ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:Hybio Pharmaceutical Co., Ltd. based inGuangdong, CHINA
Facilitate follicular development and dev elopment's synchronization,upgrade the quality of ovum,widely used in aided reproduction technology(ART),including:AI,IVI-ET,ICSI and etc; Block in vivo androgen ,in therapy of hormone dependent prostatic carcinoma; Inhibit hypothalamus-pituitary-genitical gland axis in treat precocity; Induce temporary menostasia in treating endometriosis; Adjust ...